An S. De Vriese

AZ Sint Jan Brugge Oostende AV
Brugge, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 81 publications

Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical Trial.

Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical Trial.

Journal: JAMA

Published: June 04, 2026

Off the Beaten Path: Pathogenic Mechanisms and Therapeutic Implications in Non-Complement Mediated Thrombotic Microangiopathies.

Off the Beaten Path: Pathogenic Mechanisms and Therapeutic Implications in Non-Complement Mediated Thrombotic Microangiopathies.

Journal: Kidney360

Published: January 17, 2026

Anticoagulation Decisions in Patients With Kidney Failure Requiring Hemodialysis: Caught Between a Clot and a Hard Place.

Anticoagulation Decisions in Patients With Kidney Failure Requiring Hemodialysis: Caught Between a Clot and a Hard Place.

Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation

Published: January 04, 2026

Confirmation of monotypic immunofluorescence staining by mass spectrometry in a case of proliferative glomerulonephritis.

Confirmation of monotypic immunofluorescence staining by mass spectrometry in a case of proliferative glomerulonephritis.

Journal: Histopathology

Published: December 16, 2025

Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) Trial.

Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) Trial.

Journal: American journal of nephrology

Published: December 09, 2025

Endogenous tissue restoration in a hemodialysis conduit: Performance and safety after 1-year of follow-up.

Endogenous tissue restoration in a hemodialysis conduit: Performance and safety after 1-year of follow-up.

Journal: The journal of vascular access

Published: November 22, 2025

Anti-CD38 Therapy With Daratumumab in High-Risk IgA Nephropathy.

Anti-CD38 Therapy With Daratumumab in High-Risk IgA Nephropathy.

Journal: Kidney international reports

Published: October 16, 2025

Anticoagulation for Atrial Fibrillation in Kidney Failure: A Call to Arms.

Anticoagulation for Atrial Fibrillation in Kidney Failure: A Call to Arms.

Journal: Journal of the American Society of Nephrology : JASN

Published: March 24, 2025

The authors reply.

The authors reply.

Journal: Kidney international

Published: January 19, 2025

Prevalence and Association of Pruritus and its Current Treatment during the First Year of Dialysis: A Dutch Nocturnal and Home Dialysis Study to Improve Clinical Outcomes Study.

Prevalence and Association of Pruritus and its Current Treatment during the First Year of Dialysis: A Dutch Nocturnal and Home Dialysis Study to Improve Clinical Outcomes Study.

Journal: Kidney360

Published: July 05, 2024

Lupus nephritis: redefining the treatment goals.

Lupus nephritis: redefining the treatment goals.

Journal: Kidney international

Published: May 07, 2024

Factor XI antagonists: the discovery of the philosopher's stone?

Factor XI antagonists: the discovery of the philosopher's stone?

Journal: Clinical kidney journal

Published: April 01, 2024

Showing 1-12 of 81

Last Updated: 09/26/2026